Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in patients with hemorrhagic stroke
IRCT2016100530164N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of melatonin in intracerebral hemorrhage (ICH) and brain hemorrhage (ICH), sponsored by Tehran University of Medical Sciences. Started Dec 2016; status: completed.
02
Drugs
melatonin
03
Conditions
intracerebral hemorrhage (ICH)brain hemorrhage (ICH)
Beyond the preview
Go deeper on IRCT2016100530164N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016100530164N1.